Bawag will cap dividend distributions in the second half of 2026 and may use significant risk transfers (SRTs) or a capital raise as it builds capital ahead of completing its acquisition of Permanent TSB, while still paying a planned dividend on 2025 earnings.

Dividend cap and capital options Bawag will limit dividend payouts for the second half of 2026 as part of preparations to complete the acquisition of Permanent TSB. In its quarterly earnings statement the Austrian lender said it plans to restrict distributions in the second half of the year while still paying a planned dividend on 2025 earnings. The dividend restraint forms part of efforts to build capital buffers ahead of closing the deal. The bank said other measures under consideration include "credit protection solutions" to reduce the capital required against certain loan portfolios, and it left open the possibility of further dividend adjustments or a capital raise. How SRTs fit the plan Bawag flagged significant risk transfers (SRTs) as a central tool in its funding strategy. An SRT shifts some potential loss exposure on a pool of loans from a bank to third-party investors over an extended period, allowing the bank to lower the regulatory capital it must hold against those loans. By using SRTs, Bawag aims to free capital tied up in lending portfolios so it can deploy funds towards the purchase of Permanent TSB, preserving its capital position without immediately diluting shareholders through a large capital increase. Deal scale and strategic rationale Permanent TSB, in which the State is the majority shareholder, agreed last week to sell itself to Bawag. The acquisition would expand Bawag’s retail and SME franchises beyond Austria and Germany, broadening its deposit base and branch network in Ireland. Capital mechanics and regulatory context Banks use several levers when financing large acquisitions — retained earnings, asset sales, securitisations, rights issues, and risk-transfer deals such as SRTs. Bawag is emphasising retained earnings and credit risk transfers to free regulatory capital for the acquisition. SRTs do not remove loans from the balance sheet but change the risk weighting for regulatory capital purposes. They require regulatory approval; supervisors must be satisfied the transfer is robust and durable before permitting reduced capital requirements. Investors will watch whether Bawag can structure SRTs that meet European regulators’ criteria without creating execution risk or costing more than a capital raise.

Related Articles

Bawag will pay the planned dividend on 2025 earnings while capping additional H2 2026 distributions, and said it may use SRTs or a capital raise to help fund the Permanent TSB acquisition.

This article was created with AI assistance.